SCHEMBL7739015

SCHEMBL7739015

COc1cccc(-c2nc(-c3ccc(-c4ccccc4)cc3O)oc2NC(C)=O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.68
FLT1 P17948 1/20 0.64
FLT4 P35916 1/20 0.64
KDM4E B2RXH2 4/20 0.49
ADORA3 P0DMS8 2/20 0.49
ADORA2B P29275 2/20 0.49
ADORA1 P30542 2/20 0.49
ADORA2A P29274 1/20 0.47
HSP90AA1 P07900 2/20 0.46
HSP90AB1 P08238 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
PIK3CG P48736 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738993 0.90 KDR (0.55) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7744663 0.88 KDR (0.76) KDRFLT1FLT4KDM4EADORA1
SCHEMBL7744646 0.88 KDR (0.56) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7739007 0.86 KDR (0.51) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7739078 0.86 KDR (0.68) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7739017 0.84 KDR (0.62) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7739087 0.83 KDR (0.69) KDRFLT1FLT4KDM4EADORA1
SCHEMBL7746639 0.82 KDR (0.61) KDRFLT1FLT4KDM4EHSP90AA1
SCHEMBL7744648 0.82 KDR (0.55) KDRFLT1FLT4KDM4EADORA3
SCHEMBL7739014 0.82 KDR (0.63) KDRFLT1FLT4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed